← Back to Clinical Trials
Recruiting NCT07220681

NCT07220681 Integrated Health Care for PTSD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07220681
Status Recruiting
Phase
Sponsor Veterans Medical Research Foundation
Condition Posttraumatic Stress Disorder (PTSD)
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2026-04-23
Primary Completion 2029-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Yoga and meditationWellnessPositive affect

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 300 participants in total. It began in 2026-04-23 with a primary completion date of 2029-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to determine whether which types of integrative care, meaning a combination of psychotherapy and mind-body interventions, lead to the most changes in functioning among Veterans with posttraumatic stress disorder (PTSD). The main aims are: 1. To evaluate the impact of integrative care approaches on functional outcomes among Veterans with PTSD. 2. To examine factors relevant to the implementation of integrated treatments for PTSD from the perspective of patients, providers and administrators in the VA Healthcare System. Participants will: 1. Complete assessments at the beginning of the study and 12- and 24-weeks later. 2. Engage in 12 weeks of integrated care, with the type being randomly assigned.

Eligibility Criteria

Inclusion Criteria: * clinical diagnosis * eligibility for Cognitive Processing Therapy (CPT) at a participating VA site * able to consent to study activities Exclusion Criteria: * current, active engagement in one of the included approaches (per clinician judgment) * medical conditions that contraindicate engaging in the experimental interventions

Contact & Investigator

Central Contact

Ariel J Lang, PhD, MPH

✉ ariel.lang@va.gov

📞 858-552-8585

Frequently Asked Questions

Who can join the NCT07220681 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Posttraumatic Stress Disorder (PTSD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07220681 currently recruiting?

Yes, NCT07220681 is actively recruiting participants. Contact the research team at ariel.lang@va.gov for enrollment information.

Where is the NCT07220681 trial being conducted?

This trial is being conducted at Little Rock, United States, San Diego, United States, Durham, United States, Portland, United States and 1 additional location.

Who is sponsoring the NCT07220681 clinical trial?

NCT07220681 is sponsored by Veterans Medical Research Foundation. The trial plans to enroll 300 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology